the Treatment of Multiple System Atrophy Parkinsonian Variant (MSA-P)
1 clinical trials · Condition
◉ Watch the Treatment of Multiple System Atrophy Parkinsonian Variant (MSA-P)
| Record | Firm | Date |
|---|---|---|
| The Safety, Tolerability, and Efficacy of Dopaminergic Neural Progenitor Cells (XS411CN Cell Injection) for the Treatment of Multiple System Atrophy Parkinsonian Variant (MSA-P). (NCT07617012) | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | 2026-06-15 |
Track the Treatment of Multiple System Atrophy Parkinsonian Variant (MSA-P) automatically
Every clearance here is in the API, with alerts when new ones post.